EDESA BIOTECH, INC. Gain (Loss) on Extinguishment of Debt
EDESA BIOTECH, INC. (EDSA) reported Gain (Loss) on Extinguishment of Debt of $0 for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2025-12-12
- EDESA BIOTECH, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- EDESA BIOTECH, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was $0.00.
- EDESA BIOTECH, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was $0.00.
- EDESA BIOTECH, INC. gain (loss) on extinguishment of debt for the quarter ending 2024-06-30 was $0.00.
- EDESA BIOTECH, INC. gain (loss) on extinguishment of debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- EDESA BIOTECH, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $14.77K.
- EDESA BIOTECH, INC. gain (loss) on extinguishment of debt for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $0.00 derived: sum of 2 quarters · filed 2025-12-12 | $0.00 10-K · filed 2025-12-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |||
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $0.00 derived: sum of 2 quarters · filed 2025-12-12 | $14.77K 10-K · filed 2025-12-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $14.77K 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $14.77K 10-Q · filed 2025-05-14 | |||
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | $0.00 10-K · filed 2024-12-13 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |